Siemens AG will sell 30% of its stake in Siemens Healthineers, the medical technology unit, directly to Siemens shareholders. The move reduces Siemens’ ownership from 67% to 37%, with plans to potentially go as low as 20%. Siemens will not receive cash from the transfer.
CEO Roland Busch described the spin-off as “the next phase of growth” for Siemens, allowing the company to concentrate on industrial and building automation, mobility, and industrial AI. The deconsolidation is expected to simplify governance, increase transparency, and provide strategic flexibility for both entities.
The spin-off remains subject to shareholder approval and standard regulatory clearance. Siemens expects further updates in Q2 of fiscal 2026. The company also reaffirmed its commitment to a progressive dividend policy post-deconsolidation.
Related News